Integer (NYSE:ITGR) Releases Quarterly Earnings Results, Beats Expectations By $0.06 EPS

Integer (NYSE:ITGR) announced its quarterly earnings results on Thursday. The medical equipment provider reported $1.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.70 by $0.06, Briefing.com reports. The firm had revenue of $472.06 million during the quarter, compared to analyst estimates of $462.73 million. Integer had a return on equity of 13.26% and a net margin of 5.55%.Integer’s quarterly revenue was up 5.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.43 earnings per share. Integer updated its FY 2026 guidance to 6.290-6.780 EPS.

Here are the key takeaways from Integer’s conference call:

• Integer delivered a strong FY‑2025 beat with sales up 8% reported (6% organic), adjusted EPS up 21%, expanded adjusted operating margin ~76 bps, and repurchased $50M in Q4 while announcing a ~$50M accelerated share repurchase.
• The 2026 outlook was narrowed and includes an expected 3%–4% headwind from three new products (two in electrophysiology, one in neuromodulation) that had lower‑than‑expected market adoption, driving flat to +3% organic sales guidance and near‑term margin pressure (Q1 operating margin down ~200–250 bps year‑over‑year).
• Capital and cash generation remain solid — FY‑2025 free cash flow was $105M, net total debt is ~$1.19B (3.0x trailing EBITDA), management reaffirmed disciplined capital allocation with continued M&A and buybacks and expects 2026 free cash flow of $100M–$120M.
• Management highlights a diversified, high‑value pipeline (about 40 CRM&N development customers) and expects PMA‑related customers to grow ~15%–20% CAGR over 3–5 years and aims to return to 200 bps above‑market organic growth with margin expansion by 2027, though this is forward‑looking and contingent on product launches.

Integer Stock Up 2.2%

Integer stock opened at $84.80 on Friday. Integer has a 1-year low of $62.00 and a 1-year high of $136.06. The business has a fifty day moving average price of $82.83 and a 200-day moving average price of $88.25. The company has a debt-to-equity ratio of 0.69, a current ratio of 3.32 and a quick ratio of 2.45. The stock has a market capitalization of $2.97 billion, a price-to-earnings ratio of 29.55, a PEG ratio of 0.76 and a beta of 0.77.

Institutional Investors Weigh In On Integer

A number of large investors have recently modified their holdings of the business. Parkside Financial Bank & Trust raised its position in shares of Integer by 135.5% in the 4th quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock valued at $36,000 after purchasing an additional 267 shares during the last quarter. Arax Advisory Partners increased its stake in Integer by 2,489.5% during the 4th quarter. Arax Advisory Partners now owns 492 shares of the medical equipment provider’s stock valued at $39,000 after purchasing an additional 473 shares in the last quarter. EverSource Wealth Advisors LLC raised its holdings in shares of Integer by 210.5% in the second quarter. EverSource Wealth Advisors LLC now owns 534 shares of the medical equipment provider’s stock worth $66,000 after buying an additional 362 shares during the last quarter. Northwestern Mutual Wealth Management Co. lifted its stake in shares of Integer by 861.1% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 692 shares of the medical equipment provider’s stock worth $85,000 after buying an additional 620 shares during the period. Finally, State of Wyoming lifted its position in Integer by 434.2% during the 4th quarter. State of Wyoming now owns 1,608 shares of the medical equipment provider’s stock worth $126,000 after acquiring an additional 1,307 shares during the period. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Wall Street Analysts Forecast Growth

ITGR has been the topic of several research reports. Bank of America lowered Integer from a “buy” rating to a “neutral” rating and set a $87.00 price target on the stock. in a research note on Friday, October 24th. Wall Street Zen lowered shares of Integer from a “buy” rating to a “hold” rating in a report on Sunday, January 25th. Wells Fargo & Company upped their price target on shares of Integer from $72.00 to $84.00 and gave the stock an “equal weight” rating in a research report on Friday. Truist Financial increased their price objective on shares of Integer from $95.00 to $97.00 and gave the company a “buy” rating in a research note on Friday. Finally, Piper Sandler reduced their price objective on shares of Integer from $155.00 to $82.00 and set an “overweight” rating for the company in a research note on Friday, October 24th. Four investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $101.25.

Integer News Summary

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Q4 results beat expectations — EPS $1.76 vs. $1.70 est and revenue $472.1M vs. $462.7M; full-year results showed 8% sales growth and strong adjusted EPS growth, supporting the company narrative of improving margins and growth execution. Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2025
• Positive Sentiment: Truist raised its price target to $97 and kept a “buy” rating, signaling an analyst view of meaningful upside versus the current level. Benzinga — Truist raises target
• Neutral Sentiment: Wells Fargo also raised its target (to $84) but kept an “equal weight” rating — a modest signal that the stock is fairly valued near current levels rather than a clear endorsement. Benzinga — Wells Fargo raises target
• Neutral Sentiment: Full earnings materials (slide deck and call transcript) are available for deeper review of segment trends, backlog and margin drivers — useful for investors deciding if the beat is sustainable. Q4 Results – Earnings Call Presentation Q4 Earnings Call Transcript
• Negative Sentiment: Market reaction was mixed: some investors sold after management’s FY2026 guidance was viewed as softer than hoped, leading to an earlier pullback. Zacks notes shares fell despite the beat because guidance tempered enthusiasm. ITGR Shares Down Despite Q4 Earnings & Revenues Beat Estimates
• Negative Sentiment: Wider context: guidance midpoint and revenue outlook left some analysts noting modest downside risk versus certain targets, which could cap upside until visibility improves. MarketBeat — Earnings & Guidance Details

Integer announced that its board has authorized a share buyback program on Tuesday, November 4th that allows the company to repurchase $200.00 million in shares. This repurchase authorization allows the medical equipment provider to buy up to 8.3% of its shares through open market purchases. Shares repurchase programs are often a sign that the company’s board of directors believes its shares are undervalued.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.